The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 11, 2022

Filed:

May. 30, 2018
Applicant:

Somalogic, Inc., Boulder, CO (US);

Inventors:

Sheri K. Wilcox, Longmont, CO (US);

Deborah Ayers, Broomfield, CO (US);

Nebojsa Janjic, Boulder, CO (US);

Larry Gold, Boulder, CO (US);

Michael Riel-Mehan, San Marcos, CA (US);

Thale Jarvis, Boulder, CO (US);

Assignee:

SomaLogic, Inc., Boulder, CO (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 33/68 (2006.01); C12Q 1/6886 (2018.01); G01N 33/574 (2006.01); G16B 20/00 (2019.01); G16B 99/00 (2019.01); G16B 20/20 (2019.01); G16B 25/10 (2019.01); G16B 40/30 (2019.01); G16B 25/00 (2019.01); G16B 40/00 (2019.01);
U.S. Cl.
CPC ...
G01N 33/6893 (2013.01); C12Q 1/6886 (2013.01); G01N 33/57423 (2013.01); G16B 20/00 (2019.02); G16B 20/20 (2019.02); G16B 25/10 (2019.02); G16B 40/30 (2019.02); G16B 99/00 (2019.02); C12Q 2600/106 (2013.01); C12Q 2600/112 (2013.01); C12Q 2600/156 (2013.01); C12Q 2600/16 (2013.01); G16B 25/00 (2019.02); G16B 40/00 (2019.02);
Abstract

The present application includes biomarkers, methods, devices, reagents, systems, and kits for the detection and diagnosis of lung cancer. In one aspect, the application provides biomarkers that can be used alone or in various combinations to diagnose lung cancer or permit the differential diagnosis of pulmonary nodules as benign or malignant. In another aspect, methods are provided for diagnosing lung cancer in an individual, where the methods include detecting, in a biological sample from an individual, at least one biomarker value corresponding to at least one biomarker selected from the group of biomarkers provided in Table 18, Table 20, or Table 21, wherein the individual is classified as having lung cancer, or the likelihood of the individual having lung cancer is determined, based on the at least one biomarker value.


Find Patent Forward Citations

Loading…